| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/16/2001 | US6303848 Method for conferring herbicide, pest, or disease resistance in plant hosts |
| 10/16/2001 | US6303847 Nucleotide sequence; for transgenic plants |
| 10/16/2001 | US6303846 Gene encoding oxalate decarboxylase from aspergillus phoenices |
| 10/16/2001 | US6303845 HS-40 enhancer-containing vector |
| 10/16/2001 | US6303799 Polynucleotide crosslinking agents |
| 10/16/2001 | US6303779 Process for isolating and purifying viruses and sugars from plant sources |
| 10/16/2001 | US6303775 Polynucleotides labelled with asymmetric benzoxanthene dyes |
| 10/16/2001 | US6303773 Deprotection of RNA |
| 10/16/2001 | US6303771 Pth |
| 10/16/2001 | US6303769 Lerk-5 dna |
| 10/16/2001 | US6303767 Nucleotide sequences; recombinant production; antibiotics; agricultural chemicals; veterinary medicine |
| 10/16/2001 | US6303766 Soybean phytase and nucleic acid encoding the same |
| 10/16/2001 | US6303765 Polynucleotide which codes for protein of defined amino acids sequence; recombinant production; anticarcinogenic agents; antiarthritic agents; treatment of immune disorders such as multiple sclerosis and myasthenia gravis; diagnosis |
| 10/16/2001 | US6303755 Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies |
| 10/16/2001 | US6303754 Recombinant procvf |
| 10/16/2001 | US6303753 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 10/16/2001 | US6303751 Human metabotropic glutamate receptor and related DNA compounds |
| 10/16/2001 | US6303750 Amino acid sequences; diagnosis and treatment of rheumatoid arthritis; antiarthritic agents |
| 10/16/2001 | US6303749 Amino acid sequences; for modification of feeding behavior |
| 10/16/2001 | US6303571 To screen for antibacterial compounds; genetic immunization; therapy and prophylaxis |
| 10/16/2001 | US6303383 Temperature sensitive plasmid for coryneform bacteria |
| 10/16/2001 | US6303382 Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity |
| 10/16/2001 | US6303381 Nucleotide sequences; for use as tools in genetic analysis |
| 10/16/2001 | US6303380 Construction of retroviral producer cells from adenoviral and retroviral vectors |
| 10/16/2001 | US6303379 Transfected cells for use in treatment of genetic disorder |
| 10/16/2001 | US6303378 Collision with polycation under turbulent mixing |
| 10/16/2001 | US6303377 Biotin biosynthesis in bacillus subtilis |
| 10/16/2001 | US6303376 Stimulation using cellular dna synthesis or repair mechanisms |
| 10/16/2001 | US6303375 Apparatus for aggregation propagation; for use in treatment of liver; for use as artificial liver |
| 10/16/2001 | US6303374 By hybridization with nucleic acid; controlling apoptosis and programmed cell death; alzheimer*s, parkinson*s, autoimmune, and viral diseases; cancer; amyotrophic lateral sclerosis |
| 10/16/2001 | US6303373 Method of measuring plasma membrane targeting of GLUT4 |
| 10/16/2001 | US6303372 cDNA molecule encoding human CIF130 |
| 10/16/2001 | US6303371 Method of purified rAAV vector production in non-human cell line transfected with cocksackie and adenovirus receptor |
| 10/16/2001 | US6303370 Tissue-specific regulatory elements |
| 10/16/2001 | US6303369 Plasmid for generating preferential polypeptides; for use as a tool in genetic engineering |
| 10/16/2001 | US6303365 Herbicides, antibiotics, and antimalarial agents |
| 10/16/2001 | US6303364 Bacillus thuringiensis toxins with improved activity |
| 10/16/2001 | US6303362 Generating genetically engineered viral genome; provide plasmids, incubate plasmids with restriction enzyme, mix products and ligate, screen libraries |
| 10/16/2001 | US6303361 Human glandular kallikrein-1 (hK2) |
| 10/16/2001 | US6303360 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 10/16/2001 | US6303359 DNA molecule encoding new aminopeptidase, and method of producing the aminopeptidase |
| 10/16/2001 | US6303358 Enzymatic polypeptide for use in the treatment of alzheimer's neuropathies, and diabetes |
| 10/16/2001 | US6303357 L-α-glycerophosphate oxidase gene, recombinant DNA, and method for producing modified L-α-glycerophosphate oxidase gene |
| 10/16/2001 | US6303354 Fermentation; removal of isatin or indirubin by enzyme; by-product inhibition |
| 10/16/2001 | US6303352 Fermentation; culturing microorganism that expresses recombinant methylglyoxal synthase and also aldose reductase, glycerol dehydrogenase, and/or pyridine nucleotide transferase activity |
| 10/16/2001 | US6303349 Contacting chroman-3-acetic acid ester with ester hydrolase to hydrolyze to chroman-3-acetic acid |
| 10/16/2001 | US6303348 DNA coding for protein which confers on bacterium escherichia coli resistance to L-homoserine and method for producing L-amino acids |
| 10/16/2001 | US6303345 Use of a virus DNA as promoter |
| 10/16/2001 | US6303344 Methods and compositions for polypeptide engineering |
| 10/16/2001 | US6303342 Recombinant methods and materials for producing epothilones C and D |
| 10/16/2001 | US6303341 Genetically engineered antibody for use in immunotherapy |
| 10/16/2001 | US6303340 Isolating preferential fusion protein; express fusion protein in cell, recover inclusion bodies, split fusion protein, solubilize split products, isolate protein |
| 10/16/2001 | US6303338 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of mammary gland cancer, and pathologic defects |
| 10/16/2001 | US6303334 Nucleotide sequences coding polypeptides for use in as a viricide and in gene therapy |
| 10/16/2001 | US6303333 Expression vector which codes polypeptides for the diagnosis and treatment of cancer, dietetics, inflammation, cardiovascular disorders, crohn's diseases, neuropathies and immune defects |
| 10/16/2001 | US6303332 Corn cDNA encoding southern leaf blight resistance |
| 10/16/2001 | US6303331 Vertebrate apoptosis gene: compositions and methods |
| 10/16/2001 | US6303330 Geranyl diphosphate synthase large subunit, and methods of use |
| 10/16/2001 | US6303329 Generation of active human capase; pass solution of protein through matrix, concentrate protein, activate proenzyme |
| 10/16/2001 | US6303328 Anticarcinogenic agents |
| 10/16/2001 | US6303327 Gene trap construct for identification and isolation of genes |
| 10/16/2001 | US6303322 Testing in multiplicity of wells; generating thermal unfolding or denaturation curve; combinatorial chemistry; receptor binding assay |
| 10/16/2001 | US6303320 Polypeptide of protein P140 and DNAs encoding it |
| 10/16/2001 | US6303319 Cell based assay for identifying sh2-domain-specific signal transducer antagonist |
| 10/16/2001 | US6303314 T-cell receptor Vβ-Dβ-Jβ sequence and methods for its detection |
| 10/16/2001 | US6303313 Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
| 10/16/2001 | US6303312 Modifying cell phenotype; medical research and therapy |
| 10/16/2001 | US6303311 Detecting modulators of polypeptide actvities; fuse test protein to nucleotide sequence binding protein, expose fusion polypeptide to genetically engineered reporter molecule, monitor polypeptide activity |
| 10/16/2001 | US6303310 Screening library for peptides or proteins with preferential functions; provide cells and plasmid, transform cells, detect and monitor protein interactions |
| 10/16/2001 | US6303309 Method for dissociating biotin complexes |
| 10/16/2001 | US6303308 Cloning vectors and their preparation and use for mRNA expression pattern analysis |
| 10/16/2001 | US6303307 Large scale genotyping of disease and a diagnostic test for spinocerebellar ataxia type 6 |
| 10/16/2001 | US6303305 Method for quantification of an analyte |
| 10/16/2001 | US6303302 Detecting modulators of microorganism activity; provide fungus, incubate with modulator, monitor expression from fungus |
| 10/16/2001 | US6303300 Poly (organo) phosphazenes for use in synthetic transfection systems |
| 10/16/2001 | US6303299 Vitro suppression as a tool for the investigation of translation initiation |
| 10/16/2001 | US6303296 Process for aligning macromolecules by passage of a meniscus and applications |
| 10/16/2001 | US6303293 Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof |
| 10/16/2001 | US6303292 Geneticlly engineered viral polypeptides; for use in diagnosis and treatment of viral infection |
| 10/16/2001 | US6303128 Method for protein expression |
| 10/16/2001 | US6303118 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 10/16/2001 | US6303116 Genetically engineered retroviral vector particles capable of infecting non-dividing cells |
| 10/16/2001 | US6302942 Methods for removing pollutants from contaminated soil materials with a fern plant |
| 10/16/2001 | CA2176236C Tyrosinase-activator protein fusion enzyme |
| 10/16/2001 | CA2087969C Protease resistant pdgf and methods of use |
| 10/16/2001 | CA2044626C Type a platelet-derived growth factor receptor gene |
| 10/16/2001 | CA2031164C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 10/16/2001 | CA2001774C Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 10/16/2001 | CA1341305C Dna binding proteins including androgen receptor |
| 10/14/2001 | CA2344183A1 Glycoprotein having inhibitory activity against helicobacter pylori colonization |
| 10/14/2001 | CA2342482A1 Process for finding oligonucleotide sequences for nucleic acid amplification methods |
| 10/11/2001 | WO2001075454A2 Diagnosis and treatment of alzheimer's disease |
| 10/11/2001 | WO2001075453A2 Methods involving induced dimerisation by cellular components |
| 10/11/2001 | WO2001075452A2 Detection of nerve damage using marker scip |
| 10/11/2001 | WO2001075440A2 Schizophrenia related genes |
| 10/11/2001 | WO2001075437A1 Biosensor and a method for detecting macromolecular biopolymers having a biosensor |
| 10/11/2001 | WO2001075435A2 Fluorescence assay for gamma-secretase activity and inhibitors |
| 10/11/2001 | WO2001075181A2 Method of identifying ginko biloba in a plant extract by gene profiling |
| 10/11/2001 | WO2001075180A2 Sequence-dependent gene sorting techniques |
| 10/11/2001 | WO2001075178A2 Methods for identifying peptide aptamers capable of altering a cell phenotype |